CELL INTELLIGENCE · 肿瘤细胞治疗研究

HER2 T 细胞治疗乳腺癌、肿瘤：I 期临床试验（Baylor College of）

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

这是一项 I 期注册临床试验，评估 T 细胞治疗乳腺癌、肿瘤、恶性肿瘤的安全性、可行性及初步疗效。当前状态：招募中。计划入组 27 例。试验地点：美国 · 休斯顿（共 1 个中心）。登记号：NCT06251544。

下一代基于抗体的癌症治疗：抗体-药物偶联物和双特异性抗体在血液系统恶性肿瘤和实体瘤中的应用

Next-generation antibody-based therapeutics in cancer: antibody-drug conjugates bispecific antibodies across hematologic malignancies and solid tumors

晚期胃食管腺癌的当前及新兴靶向治疗

Current and Emerging Targeted Therapy in Advanced Gastroesophageal Adenocarcinoma.

解码三阴性乳腺癌的肿瘤微环境：从免疫逃逸到精准免疫治疗

Decoding the tumor microenvironment of triple-negative breast cancer: from immune evasion to precision immunotherapy.

膜结合多模态等离激元换能器用于无创、原位监测与调控抗异质性实体瘤的 CAR-T 细胞

Membrane-Bound Multimodal Plasmonic Transducers for Noninvasive, In Situ Monitoring and Control of CAR T Cells Against Heterogeneous Solid Tumors.

分泌抗 EpCAM 双特异性 T 细胞衔接器的 CAR-T 细胞克服靶向上皮来源癌时的肿瘤异质性

CAR T cells secreting anti-EpCAM bispecific T cell engagers overcome tumor heterogeneity in targeting epithelial-originated carcinomas.

心力衰竭药物预防癌症治疗相关心功能障碍：一项叙述性综述

Heart failure medication to prevent cancer therapy-related cardiac dysfunction: A narrative review.

微卫星稳定型结直肠癌的下一代精准肿瘤学：超越 RAS 和 RAF 的整合靶向治疗

Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.

卵巢癌免疫治疗进展

Advances in immunotherapies in ovarian cancer.

三阴性乳腺癌免疫检查点免疫治疗的进展

Advancements in Immune Checkpoint-Based Immunotherapy for Triple-Negative Breast Cancer.